Table 4a.
Pons phospholipid mass in SSADH deficient patient and control group
| nmol/g ww | mol % | |||||
|---|---|---|---|---|---|---|
|
|
||||||
| Patient | Mean (control) | SD (control) | Patient | Mean (control) | SD (control) | |
|
|
||||||
| EtnGpl | 26536 | 18428 | 2549* | 44.8% | 41.0% | 1.0%* |
| PtdIns | 1031 | 978 | 153 | 1.7% | 2.2% | 0.7% |
| PtdSer | 6911 | 6991 | 1572 | 11.7% | 15.4% | 1.0%* |
| ChoGpl | 18820 | 13290 | 2543* | 31.8% | 29.4% | 0.8% |
| CerPCho | 5933 | 5396 | 852 | 10.0% | 12.0% | 0.1%* |
| Total | 59231 | 45083 | 7361 | |||
| n = 1 | n = 2 | |||||
Mass values are expressed as nmol phosphorus/gram wet weight tissue and represent mean±SD of control and patient values. Molar composition values are expressed as mol % of total phosphorus. n = 2–4.
indicates significance between patient and control group, 2 SD from control mean.